Market Surges Despite Profit Drop on Revenue Strength

Dixon Technologies' stock jumped nearly 10% on May 13, 2026, defying its reported quarterly profit figures. Despite a 36% drop in net profit for the March quarter, the stock climb showed investors prioritized operational strengths and future strategies over short-term earnings issues.

Financials and Growth Drivers

Dixon's revenue rose 2.12% to ₹10,510.51 crore in Q4 FY26. This performance, coupled with strong full-year revenue of ₹49,586 crore (up 28%) and net profit of ₹1,644 crore (up 33%), provided a foundation for investor confidence. The company's ability to maintain revenue momentum, even as net profit fell to ₹256.41 crore from ₹400.82 crore in the same quarter last year, shows operational strength. This is supported by strong cash flow and a solid balance sheet, enabling continued investment in expansion. The market's reaction reflects optimism around the company's strategy to focus on higher-margin segments and its position within India's growing electronics manufacturing services (EMS) sector, rather than the quarterly profit miss.

Valuation and Sector Outlook

Dixon currently trades at a Price-to-Earnings (P/E) ratio of about 39x to 48x based on the last twelve months. This is higher than the hardware industry median P/E of about 32.35x but is more competitive than peers like Syrma SGS Technology (around 55.5x) and PG Electroplast (around 52.6x). Amber Enterprises India trades at much higher multiples, with P/E ratios from 137x to over 200x. The broader Indian EMS sector is experiencing substantial growth, expected to grow at a compound annual growth rate (CAGR) of about 27-30% through FY29. This growth is driven by government incentives like Production Linked Incentive (PLI) schemes, global supply chain shifts (like the 'China+1' strategy), and rising domestic demand. Dixon's strategy to diversify into display modules and industrial EMS fits with these sector trends. Historically, Dixon's stock has reacted to high valuations; last May, shares fell after strong results, showing high multiples can temper positive earnings reactions.

Analyst Concerns and Risks

Despite the market's short-term optimism, several factors warrant caution. A major concern is the impact of expiring Production Linked Incentive (PLI) benefits, which added about ₹350 crore to FY26 profits and are expected to reduce FY27 earnings. Rising component costs, especially for memory chips, continue to squeeze profit margins. For Q4 FY26, EBITDA margins fell to 3.9%. CLSA rates the stock Neutral, concerned that the smartphone market share is peaking and medium-term growth visibility is low. This highlights risks for Dixon's largest revenue segment. Goldman Sachs rates the stock 'Sell' with a target price of ₹9,790, expecting a weak FY27 mobile business outlook due to high DRAM prices and possible further earnings cuts. Regulatory uncertainty looms over the proposed joint venture with Vivo, which could add significant smartphone volumes. However, the deal awaits government approval and faces complications from an ongoing Enforcement Directorate probe into Vivo. Management admits missing early opportunities in industrial EMS, indicating potential agility challenges compared to faster competitors. The company's cost-plus model, though usually effective, has shown sensitivity to these operational pressures.

Future Outlook

Dixon Technologies is actively diversifying into higher-margin areas like data center servers, display modules, and industrial EMS. This aims to reduce reliance on the mobile segment and ease margin pressure. Management forecasts 12-15% revenue growth for FY27, driven by higher average selling prices (ASPs) in mobile and continued expansion in other areas. Analyst price targets show mixed views. Motilal Oswal set ₹14,600 and Macquarie ₹15,000, believing in the company's long-term potential and diversification strategy. However, JM Financial (₹11,200), CLSA (₹10,400), and Jefferies (₹10,280) offer more cautious targets, reflecting a divided outlook on the stock's short-to-medium term path amid execution risks and margin challenges.